Enfortumab Vedotin and Radiation Therapy for Bladder Cancer
Phase 1/2
19
about 2.8 years
18+
1 site in TX
What this study is about
Researchers are testing the safety and effectiveness of enfortumab vedotin combined with radiation therapy as a treatment before surgery for some people with muscle-invasive bladder cancer. The trial will use different doses to find the safest and most effective dose.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Enfortumab vedotin
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
enfortumab vedotin
Primary: Maximum Tolerated Dose (MTD) Regimen, Pathologic Complete response rate at radical cystectomy
Secondary: Adverse Events
Oncology